Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Depression

A melancholy feeling of sadness and despair. [from NCI]

MedGen UID:
8325
Concept ID:
C0011570
Mental or Behavioral Dysfunction
2.

Depression

An emotional state characterized by feelings of sadness, emptiness, and/or tearfulness. [from NCI]

MedGen UID:
137999
Concept ID:
C0344315
Finding
3.

Mania

A state of abnormally elevated or irritable mood, arousal, and or energy levels. [from HPO]

MedGen UID:
137909
Concept ID:
C0338831
Mental or Behavioral Dysfunction
4.

Depression

A condition characterized by pervasive dysphoric mood, loss of interests, and inability to experience pleasure. [from HPO]

MedGen UID:
4229
Concept ID:
C0011581
Mental or Behavioral Dysfunction
5.

Bipolar affective disorder

A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. [from MeSH]

MedGen UID:
2649
Concept ID:
C0005586
Mental or Behavioral Dysfunction
6.

Amphetamine

Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. [from SNOMEDCT_US]

MedGen UID:
266
Concept ID:
C0002658
Biologically Active Substance; Organic Chemical; Pharmacologic Substance
7.

Much

A subjective response indicating that something is or was a large amount. [from NCI]

MedGen UID:
923949
Concept ID:
C4281574
Finding
8.

Bipolar

MedGen UID:
912721
Concept ID:
CN244029
Finding
9.

Major affective disorder 1

Bipolar disorder is a mental health condition that causes extreme shifts in mood, energy, and behavior. This disorder most often appears in late adolescence or early adulthood, although symptoms can begin at any time of life.People with bipolar disorder experience both dramatic "highs," called manic episodes, and "lows," called depressive episodes. These episodes can last from hours to weeks, and many people have no symptoms between episodes. Manic episodes are characterized by increased energy and activity, irritability, restlessness, an inability to sleep, and reckless behavior. Depressive episodes are marked by low energy and activity, a feeling of hopelessness, and an inability to perform everyday tasks. People with bipolar disorder often have repeated thoughts of death and suicide, and they have a much greater risk of dying by suicide than the general population.Manic and depressive episodes can include psychotic symptoms, such as false perceptions (hallucinations) or strongly held false beliefs (delusions). Mixed episodes, which have features of manic and depressive episodes at the same time, also occur in some affected individuals.Bipolar disorder often occurs with other mental health conditions, including anxiety disorders (such as panic attacks), behavioral disorders (such as attention-deficit hyperactivity disorder), and substance abuse. [from GTR]

MedGen UID:
377615
Concept ID:
C1852197
Mental or Behavioral Dysfunction
10.

Bronchopulmonary dysplasia of newborn

A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS. [from MeSH]

MedGen UID:
2738
Concept ID:
C0006287
Disease or Syndrome
11.

Bipolar and Related Disorders

These disorders are related to both SCHIZOPHRENIA SPECTRUM AND RELATED DISORDERS and DEPRESSIVE DISORDERS in terms of symptomatology, family history, and genetics. (DSM-V) . [from MeSH]

MedGen UID:
875788
Concept ID:
C4042924
Mental or Behavioral Dysfunction
12.

Diagnosis, Psychiatric

MedGen UID:
138165
Concept ID:
C0376338
Mental or Behavioral Dysfunction
13.

Mood disorder

A category of psychiatric disorders which have as their most predominant feature a disturbance in mood. [from NCI]

MedGen UID:
99866
Concept ID:
C0525045
Mental or Behavioral Dysfunction
14.

Neurotic Depression

A term used for any state of depression that is not psychotic. [from NCI]

MedGen UID:
76370
Concept ID:
C0282126
Mental or Behavioral Dysfunction
15.

Mental disorder

A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia. [from NCI]

MedGen UID:
14047
Concept ID:
C0004936
Mental or Behavioral Dysfunction
16.

Melancholic Depression

A subtype of depression characterized by the inability to find pleasure in positive things combined with physical agitation, insomnia, or decreased appetite. [from NCI]

MedGen UID:
6288
Concept ID:
C0025193
Mental or Behavioral Dysfunction
17.

Endogenous depression

Depression which is considered strictly biological. [from NCI]

MedGen UID:
3763
Concept ID:
C0011573
Mental or Behavioral Dysfunction
18.

Bipolar affective disorder, current episode depression

The depressive stage of bipolar disorder. [from NCI]

MedGen UID:
585
Concept ID:
C0005587
Mental or Behavioral Dysfunction
19.

Tacrolimus response

Tacrolimus is an immunosuppressive agent administered to transplant recipients to prevent and treat allograft rejection. Clinical use of tacrolimus is complicated by a narrow therapeutic index and high inter-patient pharmacokinetic variability, partly due to variations within the CYP3A5 gene. Patients who are CYP3A5 extensive or intermediate metabolizers may require increased starting doses of tacrolimus. Adjustment of dose based on CYP3A5 phenotype may allow for a more rapid achievement of therapeutic drug concentrations. This particular dosing recommendation is unusual in that it is those with the extensive metabolizer phenotype (typically referred to as the "normal" metabolizer phenotype) who may require a dosage modification (here, an increase in normal starting dose), while those with the poor metabolizer phenotype often do not require a change to the starting dose. This is because, in the case of CYP3A5, extensive metabolizers are actually the minority in most worldwide populations (excluding those of African descent), while those with the poor metabolizer phenotype are the majority. Therapeutic guidelines for tacrolimus based on CYP3A5 genotype have been published in Clinical Pharmacology and Therapeutics by the Clinical Pharmacogenetics Implementation Consortium (CPIC) and are available on the PharmGKB website. [from GTR]

MedGen UID:
831835
Concept ID:
C3547403
Cell Function
20.

Mood disorder of manic type

MedGen UID:
758866
Concept ID:
C3531750
Mental or Behavioral Dysfunction
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center